These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 22852029)
1. Retroperitoneal lymphadenectomy and resection for testicular cancer: an update on best practice. Heidenreich A; Pfister D Ther Adv Urol; 2012 Aug; 4(4):187-205. PubMed ID: 22852029 [TBL] [Abstract][Full Text] [Related]
2. Primary and Postchemotherapy Retroperitoneal Lymphadenectomy for Testicular Cancer. Heidenreich A; Paffenholz P; Nestler T; Pfister D Oncol Res Treat; 2018; 41(6):370-378. PubMed ID: 29772568 [TBL] [Abstract][Full Text] [Related]
3. Postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumours of the testis. Heidenreich A; Thüer D; Polyakov S Eur Urol; 2008 Feb; 53(2):260-72. PubMed ID: 18045770 [TBL] [Abstract][Full Text] [Related]
4. Management of patients with clinical stage I nonseminomatous testicular germ cell tumours: active surveillance versus primary chemotherapy versus nerve sparing retroperitoneal lymphadenectomy. Heidenreich A; Pfister D Arch Esp Urol; 2012 Mar; 65(2):215-26. PubMed ID: 22414450 [TBL] [Abstract][Full Text] [Related]
5. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis]. Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511 [No Abstract] [Full Text] [Related]
10. Role of primary retroperitoneal lymph node dissection in stage I and low-volume metastatic germ cell tumors. Heidenreich A; Paffenholz P; Nestler T; Pfister D; Daneshmand S Curr Opin Urol; 2020 Mar; 30(2):251-257. PubMed ID: 31972635 [TBL] [Abstract][Full Text] [Related]
11. Clinical outcome of post-chemotherapy retroperitoneal lymph node dissection in metastatic nonseminomatous germ cell tumour: A systematic review. Haarsma R; Blok JM; van Putten K; Meijer RP Eur J Surg Oncol; 2020 Jun; 46(6):999-1005. PubMed ID: 32173176 [TBL] [Abstract][Full Text] [Related]
12. Laparoscopic Postchemotherapy Retroperitoneal Lymph-Node Dissection Can Be a Standard Option in Defined Nonseminomatous Germ Cell Tumor Patients. Nicolai N; Cattaneo F; Biasoni D; Catanzaro M; Torelli T; Zazzara M; Necchi A; Giannatempo P; Raggi D; Piva L; Colecchia M; Salvioni R; Stagni S J Endourol; 2016 Oct; 30(10):1112-1119. PubMed ID: 27533924 [TBL] [Abstract][Full Text] [Related]
13. Nerve-Sparing Postchemotherapy Retroperitoneal Lymph Node Dissection (PC RPLND) for Nonseminomatous Germ Cell Tumour: Experience from a Tertiary Cancer Centre. Raja A; Malik K; Kathiresan N; Radhakrishnan V Indian J Surg Oncol; 2021 Jun; 12(2):374-377. PubMed ID: 34295081 [TBL] [Abstract][Full Text] [Related]
14. Postchemotherapy Retroperitoneal Lymph Node Dissection in Patients With Nonseminomatous Testicular Cancer: A Single Center Experiences. Nowroozi M; Ayati M; Arbab A; Jamshidian H; Ghorbani H; Niroomand H; Taheri Mahmoodi M; Amini E; Salehi S; Hakima H; Fazeli F; Haghdani S; Ghadian A Nephrourol Mon; 2015 Sep; 7(5):e27343. PubMed ID: 26539420 [TBL] [Abstract][Full Text] [Related]
15. [Comments on retroperitoneal lymphadenectomy - laparoscopic versus robotic]. Heidenreich A Urologe A; 2012 May; 51(5):692-6. PubMed ID: 22532366 [TBL] [Abstract][Full Text] [Related]